Los Angeles cancer diagnostics maker Cynvenio Biosystems just raised $25.5 million, according to a regulatory filing.
The company’s been positioning itself as a contender in the precision medicine game – helping physicians navigate cancer therapy by examining cancer biomarkers in blood.
Cynvenio is known best for its LiquidBiopsy test. I
Help employers find you! Check out all the jobs and post your resume.
